McKesson Corp. (NYSE:MCK), San Francisco, CA, will acquire RxCrossroads from CVS Health (NYSE:CVS) for $735 million. RxCrossroads provides commercial support, customized pharmacy dispensing and logistics services to pharmaceutical and biotechnology manufacturers.
The acquisition will allow McKesson to grow its end-to-end offerings for manufacturers and add plasma logistics to McKesson’s manufacturer services, complementing the company’s established customer-facing plasma offerings.
Read the latest articles and see your reports.
The MDM update newsletter is your best source for news and trends in the wholesale distribution industry.
Join other distribution executives who use MDM Premium to optimize their business. Our insights and analysis help you enter the right new markets, turbocharge your sales and marketing efforts, identify business partners that help you scale, and stay ahead of your competitors.
By providing your email, you agree to receive announcements from us and our partners for our newsletter, events, surveys, and partner resources per MDM Terms & Conditions. You can withdraw consent at any time.
Wholesale distribution news and trends delivered right to your inbox.
Sign-up for our free newsletter and get:
